Oak Forest, IL — Oak Forest, Illinois

Oak Forest, IL is a clinical research site located in Oak Forest, Illinois, United States 60452.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Oak Forest, IL has participated in 1 clinical trials.

Therapeutic areas: Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration.

Sponsors: Ollin Biosciences, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oak Forest

Browse all research sites in Illinois · View every site in Oak Forest

• University Digestive Health Center
• University Retina and Macula Associates - Oak Forest
• University Retina and Macula Associates /ID# 256077
• University Retina and Macula Associates, P.C.
• University and Macula Associates
• University Retina and Macula Associates /ID# 256287
• University Retina and Macula Associates
• University Retina and macula Associates, PC
• University Retina
• Sandoz Investigational Site
• Regeneron Study Site
• Clinical Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oak Forest, IL?

Oak Forest, IL has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oak Forest, IL conducted?

Oak Forest, IL has 1 clinical trials on record. Their work covers Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration.

Is Oak Forest, IL accredited by Crixeo Clinical Trials?

Oak Forest, IL has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oak Forest, IL?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.